Sera Prognostics Commences Proposed Public Offering Of Its Class A Common Stock; No Size Or Amount Disclosed

Author: Benzinga Newsdesk | February 10, 2025 05:02pm
Sera intends to use the net proceeds from the proposed offering to expand its commercial infrastructure and capabilities in the United States, accelerate preparations for expansion in the European Union, fund additional

Sera intends to use the net proceeds from the proposed offering to expand its commercial infrastructure and capabilities in the United States, accelerate preparations for expansion in the European Union, fund additional studies designed to increase adoption of the PreTRM test, including a potential submission to the U.S. Food and Drug Administration (the "FDA") seeking broad approval of the PreTRM test, and for general corporate purposes. 
 

Posted In: SERA